Showing 1721-1730 of 3193 results for "".
Monoclonal Antibodies for Restoring a Healthy Skin Microbiome in Atopic Dermatitis Patients
https://practicaldermatology.com/topics/research-update/monoclonal-antibodies-restoring-healthy-skin-microbiome-atopic-dermatitis-patients/24566/Monoclonal Antibodies for Restoring a Healthy Skin Microbiome in Atopic Dermatitis PatientsTransitioning a Medical Dermatology Practice to a Cosmetic Dermatology Practice
https://practicaldermatology.com/topics/practice-management/transitioning-a-medical-dermatology-practice-to-a-cosmetic-dermatology-practice/22077/The transition is natural for many practices. Key is to set and follow a plan.A Growing Neuromodulator Market: Daxxify Approved
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-growing-neuromodualtor-market-daxxify-approved/23797/Revance Therapeutics’ DaxibotulinumtoxinA-lanm is now approved to treat glabellar lines.10 Things Dermatologists Need to Know About Treating Vitiligo Today
https://practicaldermatology.com/topics/pigmentary-disorders/10-things-dermatologists-need-to-know-about-treating-vitiligo-today/22988/New and emerging treatment approaches offer hope for this challenging condition.Dumbing Down of Dermatology By Evidence-Based Medicine
https://practicaldermatology.com/topics/practice-management/how-do-you-make-this-do-that/20593/Risks of Multiple Primary Melanomas
https://practicaldermatology.com/topics/practice-management/risks-of-multiple-primary-melanomas/21058/Studies offer clarity on risks and patterns after diagnosis, as well as survival outcomes.Dermatology and the ICD-10 Code Conundrum
https://practicaldermatology.com/topics/practice-management/dermatology-and-the-icd-10-code-conundrum/21372/EHRs equipped for ICD-10 can make the impending transition smooth for any practice.Dealing With Unhappy Cosmetic Patients
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dealing-with-unhappy-cosmetic-patients/23870/Tips on avoiding and appeasing difficult patients.GLP-1 Receptor Agonists and the Aesthetic Patient: Considerations for the Dermatologist
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-and-the-aesthetic-patient/48900/The impact of glucagon-like peptide-1 agonists (GLP-1), such as semaglutide, tirzepatide and liraglutide, has transformed the healthcare industry and, in particular, aesthetic dermatology. The most common intended use of these medications, namely diabetes management and weight loss, can lead to a muStaphylococcus aureus Colonization
https://practicaldermatology.com/issues/september-2025/staphylococcus-aureus-colonization/37626/In a recent review article, Piewngam and Otto examined the epidemiology, mechanisms, and clinical implications of Staphylococcus aureus (S. aureus) colonization, while evaluating both current and emerging strategies for decolonization.